Astrana Health, Inc. (NASDAQ:ASTH) Given Average Rating of “Moderate Buy” by Brokerages

Astrana Health, Inc. (NASDAQ:ASTH) has received an average rating of “Moderate Buy” from the eleven brokerages that are presently covering the company, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and eight have issued a buy rating on the company. The average 12-month price target among analysts that have issued ratings on the stock in the last year is $41.3333.

A number of research analysts have recently weighed in on ASTH shares. Needham & Company LLC assumed coverage on Astrana Health in a research report on Friday, December 12th. They issued a “buy” rating and a $28.00 price target for the company. Weiss Ratings reissued a “sell (d+)” rating on shares of Astrana Health in a research note on Monday, December 29th. Barclays cut their target price on shares of Astrana Health from $36.00 to $26.00 and set an “equal weight” rating for the company in a research report on Monday, November 24th. Jefferies Financial Group reiterated a “buy” rating on shares of Astrana Health in a research report on Tuesday, November 25th. Finally, TD Cowen cut their price objective on Astrana Health from $40.00 to $35.00 and set a “buy” rating for the company in a research report on Monday, November 10th.

Institutional Trading of Astrana Health

A number of large investors have recently made changes to their positions in the stock. Signaturefd LLC raised its stake in Astrana Health by 57.9% in the 4th quarter. Signaturefd LLC now owns 1,058 shares of the company’s stock valued at $26,000 after purchasing an additional 388 shares during the last quarter. GAMMA Investing LLC grew its holdings in shares of Astrana Health by 144.7% during the fourth quarter. GAMMA Investing LLC now owns 1,473 shares of the company’s stock worth $37,000 after buying an additional 871 shares in the last quarter. Covestor Ltd raised its position in shares of Astrana Health by 210.6% in the third quarter. Covestor Ltd now owns 3,233 shares of the company’s stock valued at $92,000 after buying an additional 2,192 shares during the last quarter. Tower Research Capital LLC TRC boosted its position in Astrana Health by 323.3% during the second quarter. Tower Research Capital LLC TRC now owns 4,605 shares of the company’s stock worth $115,000 after acquiring an additional 3,517 shares during the last quarter. Finally, State of Wyoming purchased a new stake in Astrana Health in the 2nd quarter worth approximately $132,000. Institutional investors and hedge funds own 52.77% of the company’s stock.

Astrana Health Trading Up 1.5%

Shares of ASTH opened at $22.74 on Friday. Astrana Health has a twelve month low of $20.12 and a twelve month high of $39.97. The company has a current ratio of 1.40, a quick ratio of 1.40 and a debt-to-equity ratio of 1.27. The firm has a market capitalization of $1.28 billion, a P/E ratio of 119.69, a PEG ratio of 0.67 and a beta of 0.87. The firm’s 50-day moving average is $24.60 and its two-hundred day moving average is $26.86.

Astrana Health (NASDAQ:ASTH) last released its quarterly earnings results on Thursday, November 6th. The company reported $0.01 earnings per share for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.46). The firm had revenue of $956.05 million during the quarter, compared to analyst estimates of $952.83 million. Astrana Health had a return on equity of 1.26% and a net margin of 0.33%.The business’s revenue was up 99.7% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.33 EPS. On average, research analysts predict that Astrana Health will post 1.15 earnings per share for the current fiscal year.

About Astrana Health

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans.